Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Hepatitis Drugs Market 2011-2015

Posted on: 09 Oct 12

PR Newswire

NEW YORK,, Oct. 9, 2012

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Hepatitis Drugs Market 2011-2015

TechNavio's analysts forecast the Global Hepatitis Drugs market to grow at a CAGR of 12.42 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in demand for hepatitis drugs in developing countries. The Global Hepatitis Drugs market has also been witnessing an increase in the number of mergers and acquisitions. However, the shortage of hepatitis drugs to meet market demand could pose a challenge to the growth of this market.

TechNavio's report, the Global Hepatitis Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Bristol-Myers Squibb Co., Gilead Sciences Inc., GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Merck & Co. Inc.

Other vendors mentioned in the report: :

Dainippon Sumitomo Pharma Co. Ltd., Vertex Pharmaceuticals Inc., Novartis AG, Abbott Laboratories, Achillion Pharmaceuticals Inc., Boehringer Ingelheim GmbH, and Idenix Pharmaceuticals Inc.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow?

What key trends is this market subject to?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

01. Executive Summary

02. Introduction

03. Market Coverage

Market Overview

Key Products

04. Market Landscape

04.1 Overall Global Hepatitis Drugs Market

Market Size

Market Forecast

04.2 Key Market Segmentation

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatitis E

04.3 Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries




07. Rate of Incidence and Prevalence

Hepatitis A

Hepatitis B

Hepatitis C

08. Vendor Landscape

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

15.1 Hoffmann-La Roche Ltd.

Business Overview

SWOT Analysis

15.2 GlaxoSmithKline plc

Business Overview

SWOT Analysis

15.3 Merck & Co. Inc.

Business Overview

SWOT Analysis

15.4 Gilead Sciences Inc.

Business Overview

SWOT Analysis

15.5 Bristol-Myers Squibb Co.

Business Overview

SWOT Analysis

16. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Hepatitis Drugs Market 2011-2015 (US$ billion)

Exhibit 2: Global Hepatitis Market by Category Segmentation

Exhibit 3: Global Hepatitis Drugs Market by Brand Segmentation 2011

Exhibit 4: Global Hepatitis Drugs Market by Geographical Segmentation 2011

Exhibit 5: Prevalence of Hepatitis B by Geographical Segmentation

Exhibit 6: Prevalence of Hepatitis B by Country Segmentation 2011-2015

Exhibit 7: Hepatitis C Infection by Source 2011

Exhibit 8: Global Hepatitis Drugs Market by Vendor Segmentation 2011

Exhibit 9: Global Hepatitis C Drugs Market by Vendor Segmentation 2011

To order this report:

Drug_and_Medication Industry: Global Hepatitis Drugs Market 2011-2015


Contact Nicolas:

US: (805)-652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

PR Newswire

Last updated on: 09/10/2012

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.